BREATHING SCIENCE INTO LIFE
LIVE

Serial Number

79430064

Owner

PNEOO B.V.

Attorney

Cheryl L. Burbach

Filing Date

Jul 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BREATHING SCIENCE INTO LIFE Trademark

Serial Number: 79430064

BREATHING SCIENCE INTO LIFE is a trademark filed by PNEOO B.V. on July 8, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

PNEOO B.V. (3 trademarks)

Commerdaelseweg 8

Entity Type: 26

Trademark Details

Filing Date

July 8, 2025

Registration Date

Not Registered

Published for Opposition

August 25, 2026

Goods & Services

Medical, biological, and pharmaceutical preparations for the treatment of pulmonary diseases; veterinary preparations for pulmonary diseases; medical, biological, and pharmaceutical preparations for preventing and treating infectious diseases, medical disorders, and diseases, namely, lung cancer; veterinary preparations for pets, cattle, livestock for preventing and treating infectious diseases, medical disorders, and diseases, namely, lung cancer; medical, biological, and pharmaceutical preparations for preventing and treating viral, bacterial, and yeast infections; veterinary preparations for pets, cattle, livestock for preventing and treating viral, bacterial, and yeast infections; medical, biological, and pharmaceutical preparations for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; regulatory proteins for medical use, namely, protein arrays for medical diagnosis purposes; pharmaceutical compounds being a component in pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the prevention of diseases of the respiratory system; diagnostic preparations for medical purposes; chemical diagnostic reagents for medical use.

Custom manufacture of pharmaceuticals; custom manufacture of pharmaceuticals, biopharmaceuticals and vaccines in relation to cell therapy, gene editing, protein replacement, and antibodies; provision of information, advice and consultancy services in the field of the aforesaid services.

Biological preparations for use in cell cultures, other than for medical or veterinary purposes, for boosting cells in the immune system for improved therapies; biological preparations for use in cell cultures, in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents in the nature of complexes of molecules for scientific research and for clinical and industrial use; proteins for use in scientific research; regulatory proteins in raw material for scientific research.

Biological research; clinical research in the field of respiratory diseases, pulmonary diseases, pulmonary surgery; medical research; research and development services in the field of pharmaceutical preparations; pharmaceutical products development; pharmaceutical product evaluation; research in the field of pharmaceuticals; testing of pharmaceuticals; pharmaceutical and medical research and development services in the field of various medical disorders, cancer, pulmonary diseases and infectious diseases; vaccine research and development services; research and development in the field of microorganisms and cells; development of gene-based medicines; drug discovery services; conducting clinical trials for pharmaceutical products for others; scientific laboratory services; laboratory research services relating to pharmaceuticals; consultation in the field of scientific risk assessment, namely, prediction and assessment of scientific risks to public and private agencies; consultancy in the field of pharmaceutical research; scientific research services in the nature of conducting clinical trials for others for assessing the efficiency of pharmaceuticals; chemical research and analysis services; medical research and development services in the field of respiratory diseases, pulmonary diseases, cancer; pharmacological research services; scientific research and development; scientific research in the field of respiratory diseases, pulmonary diseases, cancer for medical purposes; scientific research for medical purposes in the area of diseases; conducting clinical trials for others; scientific research in the field of genetics and genetic engineering; genetic research; genetic mapping for scientific purposes; DNA screening for scientific research purposes; DNA analysis services for scientific research purposes; providing scientific information in the field of medical disorders and their treatment; biotechnological research relating to enzymatic synthesis; technical research in the field of pharmaceutical studies; toxicity testing for scientific research purposes; toxicity analysis; information technology services in the nature of on-site management of information technology (IT) systems of others for the pharmaceutical and healthcare industries; conducting early evaluations in the field of new pharmaceuticals; providing scientific information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design and development of computer software relating to the medical field; design and development of computer software relating to healthcare; veterinary research; provision of scientific information and data relating to medical and veterinary research and development.

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 31, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2026 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 13, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 13, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 13, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 13, 2026 COAR
REFUSAL PROCESSED BY IB
Jan 29, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 9, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 9, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 9, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 8, 2026 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jan 7, 2026 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 2, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 1, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 25, 2025 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
APPLICATION FILING RECEIPT MAILED
Aug 15, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 14, 2025 REPR